Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
You could win a cash prize of up to £25,000 when you play the Breakthrough T1D lottery. As well as the chance to win great prizes, you’ll also help fund our research to find a cure for type 1 diabetes.
Our volunteers generously give us their time, skills and experience to tell people about our work, and to help us raise vital funds for research into better treatments and ultimately a cure for T1D.
Our ambitious new roadmap is aimed at driving significant advancements in type 1 diabetes research, treatment, and care.
Your donation helps support people living with type 1 diabetes and funds the best treatment and cure research.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
Home > News & Events > Media centre
Are you a journalist seeking information about type 1 diabetes and our mission to prevent, treat and cure the condition? We are able to provide members of the media with:
For all media enquiries in the UK please email pressoffice@breakthrought1d.org.uk. This email is monitored between 09:00 and 17:30 Monday to Friday.
Please note: the above email address is for enquiries from the media/journalists only. Please email info@breakthrought1d.org.uk with all other enquiries.
For all enquiries in the US please email media@BreakthroughT1D.org.
These lab-engineered cells have been able to evade the immune system and produce insulin for 14 months without the need for immunosuppression.
You may have seen headlines or social media posts about a new drug called tegoprubart, with some suggesting it could help people with type 1 diabetes (T1D) stop taking insulin.
We're delighted to announce that James Norton will be taking on the 2026 London Marathon for Team Breakthrough T1D.
Researchers funded by Breakthrough T1D in America have used small, electrical implant systems in lab-grown, insulin-producing cells.
A series of T1DE pilot schemes commissioned by NHS England are at risk of closure due to lack of funding.
The report calls for urgent action to close these gaps and protect vulnerable people from avoidable harm.
Breakthrough T1D is supporting a major new call to action urging Government and the sport and physical activity sector to remove barriers faced by people living with diabetes.
New research suggests that B cells play a major role in damaging protective immune cells called Tregs. Protecting Tregs could help protect insulin-producing cells in the early stages of T1D.
